Publication

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Explore advances in model-informed precision dosing (MIPD) for pediatric antimicrobial therapy, including population PK modeling,…

Certara2026 年 7 月 29 日

Publication

Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants

This study, published in Clinical Pharmacology & Therapeutics (CPT), shows how population pharmacokinetic modeling supports…

Certara2026 年 2 月 2 日

Publication

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…

Certara2025 年 10 月 31 日

Conference

ICAComP 2025

Certara2025 年 10 月 8 日

On-Demand Webinar

从数据到决策：基于模型的荟萃分析（MBMA）与 GSK 和 Certara 真实世界影响

Discover the Real-World Impact of Model-Based Meta-Analysis. Hear from experts, see case studies to advance…

Certara2025 年 6 月 18 日

Publication

推动非洲定量药理学的发展 — 从能力建设向创造就业过渡

This CPT article showcases, the Applied Pharmacometrics Training (APT) program, launched in 2021 by Pharmacometrics…

Certara2024 年 12 月 9 日

海报

健康受试者中TBA-7371的群体药代动力学建模揭示了清除率的表观自身诱导现象，并预测了结核分枝杆菌感染受试者的药代动力学

Certara2024 年 11 月 22 日

Blog

Local therapies for the global COVID-19 pandemic

Henri Merdjan explains why topical drug formulations (e.g. intranasal and/or oral) could be valuable as…

Certara2020 年 5 月 29 日

Blog

Applying decision analysis to drug development for COVID-19 & future pandemics

This blog discusses how decision analysis approaches can help drug developers to better decisions under…

Certara2020 年 4 月 30 日

Publication

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

Certara2020 年 1 月 17 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

传染性疾病

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants

Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis

ICAComP 2025

从数据到决策：基于模型的荟萃分析（MBMA）与 GSK 和 Certara 真实世界影响

推动非洲定量药理学的发展 — 从能力建设向创造就业过渡

健康受试者中TBA-7371的群体药代动力学建模揭示了清除率的表观自身诱导现象，并预测了结核分枝杆菌感染受试者的药代动力学

Local therapies for the global COVID-19 pandemic

Applying decision analysis to drug development for COVID-19 & future pandemics

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

订阅时事通讯

快捷链接

解决方案

联系我们